June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Non-human primate laser-induced NAION model for assessing neuro-rejuvenating gene therapies
Author Affiliations & Notes
  • Madhura Shah
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Drenushe Krasniqi
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Meredith S Gregory-Ksander
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Sharon Rosenzweig-Lipson
    Life Biosciences, Boston, Massachusetts, United States
  • Kasia Broniowska
    Life Biosciences, Boston, Massachusetts, United States
  • Michel Wathier
    Life Biosciences, Boston, Massachusetts, United States
  • Joan Mannick
    Life Biosciences, Boston, Massachusetts, United States
  • Jennifer Cermak
    Life Biosciences, Boston, Massachusetts, United States
  • Margarete Karg
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Shintaro Shirahama
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Nasrin Refaian
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Yuancheng Lu
    Massachusetts Institute of Technology, Cambridge, Massachusetts, United States
  • Bruce Ksander
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Matthew Lawrence
    Virscio, New Haven, Connecticut, United States
  • David Sinclair
    Harvard Medical School Blavatnik Institute, Boston, Massachusetts, United States
    Paul F. Glenn Center for Biology of Aging Research at Harvard Medical School, Boston, Massachusetts, United States
  • Joseph F. Rizzo
    Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Madhura Shah None; Drenushe Krasniqi None; Meredith Gregory-Ksander None; Sharon Rosenzweig-Lipson Life Biosciences, Code E (Employment); Kasia Broniowska Life Biosciences, Code E (Employment); Michel Wathier Life Biosciences, Code E (Employment); Joan Mannick Life Biosciences, Code E (Employment), Tornado Therapeutics , Code O (Owner); Jennifer Cermak Life Biosciences, Code I (Personal Financial Interest); Margarete Karg None; Shintaro Shirahama None; Nasrin Refaian None; Yuancheng Lu Life Biosciences, Code I (Personal Financial Interest), Life Biosciences, Code P (Patent); Bruce Ksander Life Biosciences, Code F (Financial Support); Matthew Lawrence Virscio, Code O (Owner); David Sinclair Life Biosciences, Code I (Personal Financial Interest), Life Biosciences, Code P (Patent); Joseph Rizzo Life Biosciences, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 5223. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Madhura Shah, Drenushe Krasniqi, Meredith S Gregory-Ksander, Sharon Rosenzweig-Lipson, Kasia Broniowska, Michel Wathier, Joan Mannick, Jennifer Cermak, Margarete Karg, Shintaro Shirahama, Nasrin Refaian, Yuancheng Lu, Bruce Ksander, Matthew Lawrence, David Sinclair, Joseph F. Rizzo; Non-human primate laser-induced NAION model for assessing neuro-rejuvenating gene therapies. Invest. Ophthalmol. Vis. Sci. 2023;64(8):5223.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy), which is the second most common ischemic optic neuropathy in adults, is characterized by acute, monocular, and painless visual loss due to ischemic damage at the optic nerve head. The resulting largely nonreversable vision loss has no treatment and there is a 25% lifetime risk of involvement of the fellow eye. Notably, the pathophysiology is not completely understood. As a result, animal models are needed to advance understanding of NAION and to assess emerging treatments. Existing rodent NAION models are not ideal due to differences between rodent and human visual systems. Bernstein et al first developed and tested a laser induced Non-Human Primate (NHP) NAION model. The current study examined the variability in functional and histological damage to determine its utility in evaluating novel therapies.

Methods : Wild caught African green monkeys (n=8) of comparable ocular health had NAION induced on Day 0 in OS eye: IV rose Bengal (2.5 mg/kg; 0.1 ml/kg of 25 mg/ml) was administered intravenously, then 534 nm laser applied with contact lens at 100mW for 6 seconds to 500 μm spots in each ONH quadrant. OS and OD eyes were evaluated at baseline (Day -21) and weekly until study end point (Day 35) with slit lamp, fundus photography, pERG and VEP(VERIS), cSLO, and OCT (Heidelberg Spectralis HRA with HEYEX). At endpoint, eyes were enucleated and optic nerve sections stained with PPD for axon quantification; 8 mm punches of the whole mounted retinas were collected for IHC.

Results : Laser induced NAION triggered significant RNFL swelling on OCT at the ONH by Day 7 as compared to baseline. The lowest pERG responses (absolute N95 amplitude; V 10-6) compared to baseline were on Day 42 (6.9 ±1.2 vs 2.6 ±0.33 V 10-6, P=0.0033, n=8). The macular retinal ganglion cell thickness was also reduced on Day 35 as compared to baseline (228.0 ±33.0 vs 354.1 ±7.0μm, P=0.0008) and untreated eyes (228.0 ±33.0 vs 348.8 ±7.0μm, P=0.027) which coincided with a significant reduction in the number of healthy axons in the optic nerve and reduction in macular RNFL thickness.

Conclusions : NHP laser induced ONH damage is a robust and reproducible model of NAION. Inter- and intra-subject variability of functional and histological measurements achieved statistical significance using a reasonable sample size, demonstrating the model’s utility in studies evaluating novel therapies.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×